Glenmark gets final nod for Tadalafil Tablets and tentative approvals for Gabapentin Enacarbil ER Tablets and Apremilast Tablets from US FDA Read more
Favipiravir shows significant improvement in time to clinical cure for mild to moderate COVID-19 Read more
Umifenovir addition gives no significant clinical benefit in COVID-19 treatment: Glenmark study Read more
